Faculty

Zeina M. Nabhan, MD, MS

Zeina M. Nabhan, MD, MS

Assistant Professor of Clinical Pediatrics

Zeina Nabhan, MD
Phone: (317) 944-3889
Email: znabhan@iu.edu
Address:
705 Riley Hospital Dr, Room 5960
Indianapolis, IN 46202

Bio

Specialty

Pediatric Endocrinology and Diabetology

Areas of Interest

Obesity, metablic  syndrome, dyslipidemia, and type 2 diabetes.

Dr.  Nabhan was born in Beirut, Lebanon. She attended medical school at the American University of Beirut. She did her pediatric internship at Wayne State University in Detroit Michigan. She did her pediatric residency and endocrine fellowship at Indiana University School of Medicine. She received a masters degree in clinical research from Indiana University. Dr. Nabhan has special interest in childhood obesity and Type 2 diabetes.

Education

1997 BS, Biology - American University of Beirut - Beirut, Lebanon
2001 MD - American University of Beirut - Beirut, Lebanon
2002 Pediatric Internship - Wayne State University School of Medicine - Detroit, MI
2004 Pediatric Residency - Indiana University School of Medicine - Indianapolis, IN
2007 Fellowship in Pediatric Endocrinology - Indiana University School of Medicine - Indianapolis, IN
2007 Masters of Science in Clinical Research (MS), Clinical Investigator Training Enhancement (CITE) program, Indiana University Graduate School

Honors & Awards


Clinical

Riley Hospital Outpatient Center
MSA3
705 Riley Hospital Drive
Indianapolis, IN  46202

Riley Children's Specialty Clinic
11590 North Meridian Street
Suite 300
Carmel, IN 46032

South Bend Pediatrics
211 North Eddy Street
South Bend, IN 46617

Deaconess Riley Children's Specialty Center
4133 Gateway Boulevard
Suite 220
Newburgh, IN 47630 


Research & Grants

Dr. Nabhan is engaged in clinical research projects related to type 2 diabetes in adolescents.

Current Grants

TODAY Genetics Study Research Grant
# STOPP-T2D/5U01-DK061230-09, NIH, Local PI

“Colesevelam Oral Suspension as Monotherapy or Add-on to Metformin Therapy in Pediatric subjects with Type 2 Diabetes Mellitus,” Daiichi Sankyo Pharma Research Grant, Local PI

R01 DK092717  “Computer Automation for Diagnosis & Management of Childhood Type 2 Diabetes,” NIDDK, Co-investigator


Representative PublicationsView All Publications

1. Nabhan ZM, Kreher NC, Eugster EA. Hashitoxicosis in children; clinical features and natural history. J Pediatr 2005;146:533-6.

2. Nabhan ZM, Rink RC, Eugster EA. Urinary tract infection in children with congenital adrenal hyperplasia. J Pediatr Endocrinol and Metab 2006;19:815-820.

3. Nabhan ZM, Rardin L, Meier J, Eugster EA, DiMeglio LA. Predictors of glycemic control on insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Research and Clinical Practice 2006;74:217-221.

4. Nabhan ZM, Rink RC, Eugster EA. Ambiguous genitalia without clitoromegaly in a girl with classic congenital adrenal hyperplasia. Endocrinologist 2006;16:311-312.

5. Nabhan ZM and Eugster EA. Monozygotic Twins with Turner Syndrome Develop Slipped Capital Femoral Epiphysis on Growth Hormone Therapy. Pediatrics 2006;118 (6):e1900-3.

6. Nabhan ZM and Eugster EA. Upper tract genitourinary malformations in children and adolescents with congenital adrenal hyperplasia. Pediatrics 2007;120(2):e340-7.

7. Nabhan ZM, West K, Eugster EA. Oophorectomy in McCune Albright Syndrome: a case of mistaken identity. J Pediatr Surg 2007;42(9):1578-83.

8. Nabhan ZM and Lee PA. Disorders of Sex Differentiation.Curr Opin Obstet and Gynecol 2007;19:440-445.

9. Nabhan ZM, Kreher NC, Kronenberger W, et al. A Randomized Prospective Study of Insulin Pump Versus Insulin Injection Therapy in Very Young Children withType 1 Diabetes: 12 Month Glycemic, BMI, and Neurocognitive Outcomes. Pediatric Diabetes 2009;10:202-8.

10. Nabhan ZM, St-Dennis Feezle L, Kunselman AR, Johnson NB, Lee PA. Normal adult height among girls treated for central precocious puberty with gonadotropin –releasing hormone analog therapy. J Pediatr Endocrinol and Metab, 2009;22:309-16.

11. Nabhan ZM, DiMeglio LA, Rong Qi, Perkins S, Eugster EA: Conjugated Oral versus Transdermal Estrogen Replacement in Girls with Turner Syndrome: A Pilot Comparative Study. Journal of Clinical Endocrinology and Metabolism, 2009;94:2009-15.

12. Nebesio TD, McKenna MP, Nabhan ZM, Eugster EA. Newborn screening results in children with central hypothyroidism. J Pediatr, 2010:156;990-3.

13. Nabhan ZM, Mieszczak J, Eugster EA. Combined Central Precocious Puberty and Primary Gonadal Failure after Treatment of Childhood Malignancy in 2 Boys: a Diagnostic and Therapeutic Conundrum. J Pediatr, 2010:157:507-9.

14. Goldyn AK, Nabhan ZM, Eugster EA. A comparison of referral patterns to the pediatric endocrine clinic before and after FDA approval of growth hormone for idiopathic short stature. J Pediatr Endocrinol and Metab, 2011:24:89-91

15. Nabhan ZM and Eugster EA. Medical care of girls with Turner syndrome: where are we lacking? Endocrine Practice, 2011:17(5): 747-52.

16. Nabhan ZM and Hannon TS. Cardiometabolic Risk Factors in American Children: What Can Be Learned From Current Trends? J Adolesc Health 2012:50(2):107-9.

17. Nabhan ZM, MD, Ryder KW, Fuqua JS, Nebesio TD. Discrepancies between Reported Self-Monitored Blood Glucose Results and Point-of-Care Hemoglobin